Delivery Order SPE2DB22D1106-SPE2DB24FFDN0

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir 6 mg/mL suspension in 60 mL bottles. The firm-fixed-price contract has a ceiling value of $7,429.39 and an ultimate completion date of November 28, 2022. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $1,635.32, is for the delivery of Oseltamivir 6 mg/ml suspension in 60 ml bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Oseltamivir 6 mg/mL suspension (60 mL) and has a ceiling value of $1,302.24. The contract is a firm fixed price delivery order with a performance period through February 11, 2025. This appears to be a task order awarded under a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir 6 mg/ml suspension in 60 ml bottles. The contract has a ceiling value of $3,364.10 and a performance period that extends through February 4, 2025. The contract is a firm fixed-price, delivery order type and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 60 ml bottles of 6 mg/ml oseltamivir suspension. The contract has a ceiling value of $6,953.34 and a completion date of September 19, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical for the delivery of a...
This federal contract award is for the delivery of Oseltamivir 6 mg/ml suspension in 60 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,980.40, was awarded to AmerisourceBergen Drug Corp, a pharmaceutical distribution company. The contract has a period of performance through February 22, 2024. The contract is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Oseltamivir 6 mg/ml suspension, a medication used to treat influenza. The contract has a ceiling value of $4,729.34 and is a Firm Fixed Price type with a period of performance through February 12, 2025. AmerisourceBergen is the prime contractor, and there are no set-aside requirements indicated. The contract appears to be a delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 60 ml bottles of 6 mg/ml oseltamivir suspension. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,302.24 and a completion date of March 13, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract is associated with the company's...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567847302 - OSELTAMIVIR 6 MG/ML SUSPENSION 60ML, with a ceiling value of $9,518.63. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 60 mL bottles of 6 mg/mL suspension of the antiviral drug oseltamivir. The contract has a firm fixed price of $3,467.28 and a completion date of March 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFDN0
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of oseltamivir 6 mg/ml suspension in 60 ml bottles. The contract has a ceiling value of $4,635.43 and is a firm fixed price arrangement. The award is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:59 AM